CO2023012680A2 - Emulsiones para anestésicos locales - Google Patents

Emulsiones para anestésicos locales

Info

Publication number
CO2023012680A2
CO2023012680A2 CONC2023/0012680A CO2023012680A CO2023012680A2 CO 2023012680 A2 CO2023012680 A2 CO 2023012680A2 CO 2023012680 A CO2023012680 A CO 2023012680A CO 2023012680 A2 CO2023012680 A2 CO 2023012680A2
Authority
CO
Colombia
Prior art keywords
emulsion
local anesthetic
emulsions
local anesthetics
oil
Prior art date
Application number
CONC2023/0012680A
Other languages
English (en)
Inventor
Andrew Xian Chen
Lijia Chen
Damian Mcloud
Original Assignee
Cali Biosciences Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cali Biosciences Us Llc filed Critical Cali Biosciences Us Llc
Publication of CO2023012680A2 publication Critical patent/CO2023012680A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

RESUMEN Una emulsión y el uso de una emulsión para el alivio del dolor que comprende un anestésico local, lecitina, aceite y una fase acuosa, en donde el anestésico local no es covalente unido a las gotas de aceite de la emulsión y la emulsión es física y químicamente estable y la emulsión proporciona una mejor seguridad, farmacocinética de liberación prolongada y una duración prolongada de la acción del anestésico local.
CONC2023/0012680A 2021-03-31 2023-09-26 Emulsiones para anestésicos locales CO2023012680A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163169121P 2021-03-31 2021-03-31
US17/369,369 US11992483B2 (en) 2021-03-31 2021-07-07 Emulsions for local anesthetics
PCT/US2022/021721 WO2022212166A1 (en) 2021-03-31 2022-03-24 Emulsions for local anesthetics

Publications (1)

Publication Number Publication Date
CO2023012680A2 true CO2023012680A2 (es) 2023-11-20

Family

ID=83450711

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0012680A CO2023012680A2 (es) 2021-03-31 2023-09-26 Emulsiones para anestésicos locales

Country Status (12)

Country Link
US (1) US11992483B2 (es)
EP (1) EP4313018A1 (es)
JP (1) JP2024512704A (es)
KR (1) KR20230163543A (es)
CN (1) CN117412743A (es)
AU (1) AU2022249201A1 (es)
BR (1) BR112023019572A2 (es)
CA (1) CA3212259A1 (es)
CL (1) CL2023002879A1 (es)
CO (1) CO2023012680A2 (es)
MX (1) MX2023011487A (es)
WO (1) WO2022212166A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5091188A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5693337A (en) 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
CA2319810C (en) 1998-02-10 2008-12-23 Gensia Sicor Inc. Propofol composition containing sulfite
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
JP2002520120A (ja) 1998-07-17 2002-07-09 スカイファーマ インコーポレーテッド 封入物質の制御放出のための生分解性組成物
US7261903B1 (en) 1999-02-22 2007-08-28 Guy Weinberg Lipid emulsions in the treatment of systemic poisoning
US6100302A (en) 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
US7476400B2 (en) 2001-11-13 2009-01-13 Ferndale Ip, Inc. High-concentration lidocaine compositions and methods for their preparation
AU2003222491A1 (en) 2002-05-02 2003-12-31 Fdl, Inc. Novel parenteral composition comprising propofol
US20060233721A1 (en) 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
EP1704858A4 (en) 2004-01-14 2008-06-04 Otsuka Pharma Co Ltd PROPOFOL-CONTAINING FAT-EMULSION PREPARATION
EP1711163A2 (en) 2004-02-05 2006-10-18 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
WO2006002050A1 (en) 2004-06-15 2006-01-05 Encore Therapeutics, Inc. Phospholipid compositions and methods for their preparation and use
US20070293586A1 (en) 2005-02-03 2007-12-20 Suresh Dixit Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
CN101155580A (zh) 2005-04-13 2008-04-02 株式会社大塚制药工场 含异丙酚的脂肪乳剂
US20090131538A1 (en) 2005-05-27 2009-05-21 Taro Pharmaceuticals North America, Inc. c/o Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
EA200802166A1 (ru) 2006-04-20 2009-06-30 Эмджен Инк. Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
EP2034961A1 (de) 2006-06-30 2009-03-18 Gertrud Langhoff Solubilisatformulierungen
DE102008034944B4 (de) 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
US20100105125A1 (en) 2008-10-24 2010-04-29 Bioprocessh20 Llc Systems, apparatuses and methods for cultivating microorganisms and mitigation of gases
WO2010082092A1 (en) 2009-01-13 2010-07-22 Claris Lifesciences Limited Propofol based anesthetic with preservative
CN101904814A (zh) 2009-06-04 2010-12-08 上海恒瑞医药有限公司 制备载药乳剂的方法
WO2011075623A1 (en) 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids
CN102370619A (zh) * 2010-08-18 2012-03-14 罗和国 脂肪乳乳化局麻药
EP3181121B1 (en) 2010-12-03 2020-10-28 EPI Health, LLC Pharmaceutical cream compositions comprising oxymetazoline to treat rosacea
CN102526753B (zh) 2011-12-15 2014-01-22 成都师创生物医药科技有限公司 一种以磷脂为基质的原位相变凝胶缓释系统及其制备方法
CA2871820C (en) 2012-05-10 2020-11-03 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
CN105451710A (zh) 2013-03-22 2016-03-30 利普泰股份公司 用于治疗和/或护理皮肤、粘膜和/或指甲的外泌多糖
US10426727B2 (en) 2014-04-25 2019-10-01 Wisconsin Alumni Research Foundation Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs
PT3189834T (pt) 2014-09-04 2024-03-15 Sichuan Haisco Pharmaceutical Co Ltd Utilização de agente de reforço do recetor gabaa na preparação de medicamento sedativo e anestésico
JP7425534B2 (ja) * 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
CN107708670A (zh) 2015-06-01 2018-02-16 奥托泰利克有限责任公司 磷脂包衣的治疗剂纳米颗粒和有关的方法
CA3033570C (en) 2015-08-17 2022-12-06 Sidmak Laboratories (India) Pvt. Ltd. Topical film delivery system
WO2017037663A1 (en) 2015-09-02 2017-03-09 Cadila Healthcare Limited Topical compositions comprising corticosteroids
MX2018011341A (es) 2016-03-18 2019-07-04 Int Flavors & Fragrances Inc Microcápsulas de sílice y métodos para prepararlas.
WO2017218630A2 (en) 2016-06-15 2017-12-21 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2018013595A1 (en) 2016-07-11 2018-01-18 Theracell, Inc. Bone derived fibers and oxygenated wound treatments
CN107049932B (zh) 2017-06-22 2020-11-06 四川大学 一种小分子药物原位相变凝胶缓释系统及其制备方法
CN111840553A (zh) 2019-04-15 2020-10-30 湖州依诺唯新药物制剂有限公司 脂性药物制剂及其应用
JP2022549216A (ja) 2019-09-23 2022-11-24 ディーディーエス リサーチ インク． 浸透促進剤を含有する脂質ベシクル組成物
CN113018248B (zh) 2019-12-23 2022-07-22 南京清普生物科技有限公司 一种缓释递药系统
WO2021143745A1 (zh) 2020-01-14 2021-07-22 中国科学院上海药物研究所 一种长效罗哌卡因药物组合物及其制备方法和用途
WO2021247774A1 (en) 2020-06-02 2021-12-09 The Johns Hopkins University Gel for use in gastrointestinal endoscopy and endodermal, epidermal, and other mucosal uses
JP2023546297A (ja) 2020-10-16 2023-11-01 バイオスーペリア テクノロジー，インコーポレイテッド 肺治療組成物
CN114762676B (zh) 2021-01-14 2024-03-08 南京清普生物科技有限公司 一种缓释制剂组合物
EP4297746A2 (en) 2021-02-23 2024-01-03 Edison Oncology Compositions and methods to improve the therapeutic benefit of suboptimally administered compounds and therapies for the treatment of diseases
WO2022186802A1 (en) 2021-03-01 2022-09-09 Sabanci Ahmet Uemit Liposomal ozone nanosolutions
MX2023010953A (es) 2021-03-16 2023-12-08 Josef MaŠEk Composiciones compuestas de pelicula oromucosal que comprenden particulas de epinefrina.
US20220305125A1 (en) 2021-03-27 2022-09-29 TRx Biosciences Limited Compositions Having Improved Bioavailability of Therapeutics
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics
WO2022217147A1 (en) 2021-04-09 2022-10-13 Rosenfeld Mark J Methods for improving cutaneous permeation of cannabinoids and fatty acid amides

Also Published As

Publication number Publication date
AU2022249201A1 (en) 2023-09-21
US11992483B2 (en) 2024-05-28
BR112023019572A2 (pt) 2023-11-14
JP2024512704A (ja) 2024-03-19
CL2023002879A1 (es) 2024-02-09
MX2023011487A (es) 2023-10-04
US20220313669A1 (en) 2022-10-06
CA3212259A1 (en) 2022-10-06
CN117412743A (zh) 2024-01-16
WO2022212166A1 (en) 2022-10-06
EP4313018A1 (en) 2024-02-07
KR20230163543A (ko) 2023-11-30

Similar Documents

Publication Publication Date Title
CO2023012680A2 (es) Emulsiones para anestésicos locales
DOP2017000270A (es) Composiciones farmacéuticas tópicas
CO2022002685A2 (es) Nanopartículas lipídicas mejoradas para el suministro de ácidos nucleicos
BR112016028961A8 (pt) fibras eletrotorcidas, seu método de preparação e seu uso, bem como composição, e kit
SG11201901742QA (en) Oil-in-water type emulsion having excellent stability and cosmetic composition comprising same
BR112014017920A8 (pt) Preparação cosmética e/ou dermatológica à base de uma emulsão de água em óleo e uso da combinação de dois emulsificantes de água/óleo
AR079412A1 (es) Emulsiones estables de aceite en agua
CO2021000174A2 (es) Composiciones tópicas para el alivio del dolor
CL2011001017A1 (es) Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster.
AR098076A1 (es) Dispositivo de inyección
BR112014005595A2 (pt) preparação aquosa cosmética ou dermatológica para aplicação em pele molhada ou úmida, método para cuidar da pele e método de barbear em úmido
NZ607103A (en) A water-in-oil type emulsion for treating a disease of the eye
BR112013020309A2 (pt) dispersões agroquímicas oleosas estáveis
CL2021000509A1 (es) Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisular
CL2022002606A1 (es) Implante ocular que contiene un inhibidor de la tirosina cinasa
BR112021019464A2 (pt) Seringa para uso médico
UY35825A (es) ?concentrados de emulsión pesticida que contienen aceites naturales o derivados de petróleo y métodos de uso?.
CL2020001273A1 (es) Emulsiones para el tratamiento tópico de infecciones dérmicas y de infecciones de mucosas.
BRPI0403269A (pt) emulsão múltipla
BR112015020066A8 (pt) composição na forma de uma emulsão óleo-em-água, processo cosmético para tratar e/ou cuidar das matérias queratínicas humanas, processo cosmético para tratar a transpiração humana, dispositivo de distribuição e uso de uma composição
BR112014007274A2 (pt) preparação cosmética ou dermatológica para aplicação sobre a pele molhada ou úmida e método para cuidar da pele
CO6311076A2 (es) Una composición que comprende 2-n-butil-3-[4-(3-di-n-butilaminopropoxi)benzoil]-5-metilsulfonamido-benzofurano y sus sales aceptables farmacéuticamente
AR069497A1 (es) Combianacion emulsionante
BR112017010836A2 (pt) emulsão pickering, particularmente uma emulsão cosmética, uso de um filossilicato sintético com fórmula molecular mg3si4o10(oh)2, processo para preparar uma emulsão e de tratamento cosmético
BR112014010971A2 (pt) emulsão, processo para fabricar uma emulsão, uso de uma emulsão, e, polímero